Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation - Scorecard - MDSpire

Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation

  • By

  • Ruofan He

  • Qingqing Xing

  • Songyi Liu

  • Shiwei Lin

  • Xiang Lin

  • Jianxin Ye

  • May 22, 2026

  • 0 min

Share

Clinical Scorecard: Investigating the Clinical Relevance and Functional Role of RRN3 in Gastric Cancer: Findings from a Comprehensive Pan-Cancer Analysis and Experimental Studies

At a Glance

CategoryDetail
Condition
Key MechanismsRRN3 is involved in ribosome biogenesis.
Target PopulationPatients with gastric cancer.
Care Setting

Key Highlights

  • RRN3 is upregulated in gastric cancer and associated with unfavorable overall survival.
  • High RRN3 expression correlates with immune checkpoint genes and tumor mutation burden.
  • Functional experiments indicate that RRN3 knockdown inhibits GC cell proliferation and invasion.
  • In vivo studies support RRN3's role in promoting tumor growth.

Guideline-Based Recommendations

Diagnosis

  • Evaluate RRN3 expression levels in gastric cancer tissues.

Management

    Monitoring & Follow-up

      Risks

      • High RRN3 expression may indicate poor prognosis.

      Patient & Prescribing Data

      Patients diagnosed with gastric cancer.

      Potential for RRN3-targeted therapies to improve treatment outcomes.

      Clinical Best Practices

        Related Resources & Content

        Original Source(s)

        Related Content